These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21072441)

  • 1. Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: a comparative study.
    Pieroni L; Finamore F; Ronci M; Mattoscio D; Marzano V; Mortera SL; Quattrucci S; Federici G; Romano M; Urbani A
    Mol Biosyst; 2011 Mar; 7(3):630-9. PubMed ID: 21072441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response.
    Mattoscio D; Evangelista V; De Cristofaro R; Recchiuti A; Pandolfi A; Di Silvestre S; Manarini S; Martelli N; Rocca B; Petrucci G; Angelini DF; Battistini L; Robuffo I; Pensabene T; Pieroni L; Furnari ML; Pardo F; Quattrucci S; Lancellotti S; Davì G; Romano M
    FASEB J; 2010 Oct; 24(10):3970-80. PubMed ID: 20530751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics investigation of human platelets by shotgun nUPLC-MSE and 2DE experimental strategies: a comparative study.
    Finamore F; Pieroni L; Ronci M; Marzano V; Mortera SL; Romano M; Cortese C; Federici G; Urbani A
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s140-8. PubMed ID: 20606744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of nasal cells from cystic fibrosis patients and non-cystic fibrosis control individuals: search for novel biomarkers of cystic fibrosis lung disease.
    Roxo-Rosa M; da Costa G; Luider TM; Scholte BJ; Coelho AV; Amaral MD; Penque D
    Proteomics; 2006 Apr; 6(7):2314-25. PubMed ID: 16518875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the lung proteome in cystic fibrosis.
    Gharib SA; Vaisar T; Aitken ML; Park DR; Heinecke JW; Fu X
    J Proteome Res; 2009 Jun; 8(6):3020-8. PubMed ID: 19354268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative differential proteomics of cystic fibrosis cell models by SILAC (stable isotope labelling in cell culture).
    Guerrera IC; Ollero M; Vieu DL; Edelman A
    Methods Mol Biol; 2011; 742():213-25. PubMed ID: 21547735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling pathways of proteostasis network unraveled by proteomic approaches on the understanding of misfolded protein rescue.
    Gomes-Alves P; Neves S; Penque D
    Methods Enzymol; 2011; 491():217-33. PubMed ID: 21329803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis heterozygotes do not have increased platelet activation.
    Tarnow I; Michelson AD; Frelinger AL; Linden MD; Li Y; Fox ML; Barnard MR; O'Sullivan BP
    Thromb Res; 2007; 121(2):159-62. PubMed ID: 17532368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic biomarker discovery for the monogenic disease cystic fibrosis.
    Penque D
    Expert Rev Proteomics; 2007 Apr; 4(2):199-209. PubMed ID: 17425456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum proteomics signature of cystic fibrosis patients: a complementary 2-DE and LC-MS/MS approach.
    Charro N; Hood BL; Faria D; Pacheco P; Azevedo P; Lopes C; de Almeida AB; Couto FM; Conrads TP; Penque D
    J Proteomics; 2011 Jan; 74(1):110-26. PubMed ID: 20950718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis enters the proteomics scene: new answers to old questions.
    Ollero M; Brouillard F; Edelman A
    Proteomics; 2006 Jul; 6(14):4084-99. PubMed ID: 16791827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells.
    Singh OV; Vij N; Mogayzel PJ; Jozwik C; Pollard HB; Zeitlin PL
    J Proteome Res; 2006 Mar; 5(3):562-71. PubMed ID: 16512671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible dysregulation of chaperon and metabolic proteins in cystic fibrosis bronchial tissue.
    Frischer T; Myung JK; Maurer G; Eichler I; Szepfalusi Z; Lubec G
    Proteomics; 2006 Jun; 6(11):3381-8. PubMed ID: 16637013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (delta-f508) cystic fibrosis transmembrane conductance regulator.
    Bhaskar KR; Turner BS; Grubman SA; Jefferson DM; LaMont JT
    Hepatology; 1998 Jan; 27(1):7-14. PubMed ID: 9425910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways.
    Verhaeghe C; Remouchamps C; Hennuy B; Vanderplasschen A; Chariot A; Tabruyn SP; Oury C; Bours V
    Biochem Pharmacol; 2007 Jun; 73(12):1982-94. PubMed ID: 17466952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsense mutation R1162X of the cystic fibrosis transmembrane conductance regulator gene does not reduce messenger RNA expression in nasal epithelial tissue.
    Rolfini R; Cabrini G
    J Clin Invest; 1993 Dec; 92(6):2683-7. PubMed ID: 7504691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of hosts and pathogens in cystic fibrosis.
    Kamath KS; Kumar SS; Kaur J; Venkatakrishnan V; Paulsen IT; Nevalainen H; Molloy MP
    Proteomics Clin Appl; 2015 Feb; 9(1-2):134-46. PubMed ID: 25418359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
    J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.